Literature DB >> 26555178

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose.

Venkatesh Krishnan1, Robert Clark1, Marina Chekmareva2, Amy Johnson1, Sophia George3, Patricia Shaw4, Victoria Seewaldt5, Carrie Rinker-Schaeffer6.   

Abstract

High-grade serous ovarian cancer (HGSC), the cause of widespread peritoneal metastases, continues to have an extremely poor prognosis; fewer than 30% of women are alive 5 years after diagnosis. The omentum is a preferred site of HGSC metastasis formation. Despite the clinical importance of this microenvironment, the contribution of omental adipose tissue to ovarian cancer progression remains understudied. Omental adipose is unusual in that it contains structures known as milky spots, which are comprised of B, T, and NK cells, macrophages, and progenitor cells surrounding dense nests of vasculature. Milky spots play a key role in the physiologic functions of the omentum, which are required for peritoneal homeostasis. We have shown that milky spots also promote ovarian cancer metastatic colonization of peritoneal adipose, a key step in the development of peritoneal metastases. Here we describe the approaches we developed to evaluate and quantify milky spots in peritoneal adipose and study their functional contribution to ovarian cancer cell metastatic colonization of omental tissues both in vivo and ex vivo. These approaches are generalizable to additional mouse models and cell lines, thus enabling the study of ovarian cancer metastasis formation from initial localization of cells to milky spot structures to the development of widespread peritoneal metastases.

Entities:  

Mesh:

Year:  2015        PMID: 26555178      PMCID: PMC4692646          DOI: 10.3791/52721

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

1.  Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models.

Authors:  Robert Clark; Venkatesh Krishnan; Michael Schoof; Irving Rodriguez; Betty Theriault; Marina Chekmareva; Carrie Rinker-Schaeffer
Journal:  Am J Pathol       Date:  2013-08       Impact factor: 4.307

Review 2.  The omentum: anatomical, metabolic, and surgical aspects.

Authors:  Danielle Collins; Aisling M Hogan; Donal O'Shea; Des C Winter
Journal:  J Gastrointest Surg       Date:  2009-03-17       Impact factor: 3.452

3.  The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

4.  Ovarian cancer risk and family history.

Authors:  W D Foulkes; S A Narod
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

Review 5.  The distal fallopian tube: a new model for pelvic serous carcinogenesis.

Authors:  Christopher P Crum; Ronny Drapkin; Alexander Miron; Tan A Ince; Michael Muto; David W Kindelberger; Yonghee Lee
Journal:  Curr Opin Obstet Gynecol       Date:  2007-02       Impact factor: 1.927

6.  Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice.

Authors:  A Hagiwara; T Takahashi; K Sawai; H Taniguchi; M Shimotsuma; S Okano; C Sakakura; H Tsujimoto; K Osaki; S Sasaki
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

Review 7.  Precursors to pelvic serous carcinoma and their clinical implications.

Authors:  Ann K Folkins; Elke A Jarboe; Michael H Roh; Christopher P Crum
Journal:  Gynecol Oncol       Date:  2009-02-23       Impact factor: 5.482

8.  Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth.

Authors:  Scott A Gerber; Viktoriya Y Rybalko; Chad E Bigelow; Amit A Lugade; Thomas H Foster; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 9.  Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

Authors:  Christopher P Crum; Ronny Drapkin; David Kindelberger; Fabiola Medeiros; Alexander Miron; Yonghee Lee
Journal:  Clin Med Res       Date:  2007-03

10.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

View more
  5 in total

Review 1.  Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment.

Authors:  Karen M Watters; Preety Bajwa; Hilary A Kenny
Journal:  Cancers (Basel)       Date:  2018-08-09       Impact factor: 6.639

Review 2.  Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2018-07-09       Impact factor: 6.639

3.  Lymphocyte and macrophage infiltration in omental metastases indicates poor prognosis in advance stage epithelial ovarian cancer.

Authors:  Tao Zhang; Qin Liu; Yingfan Zhu; Yizhou Huang; Jiale Qin; Xiaodong Wu; Songfa Zhang
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

4.  G6PD inhibition sensitizes ovarian cancer cells to oxidative stress in the metastatic omental microenvironment.

Authors:  Shree Bose; Qiang Huang; Yunhan Ma; Lihua Wang; Grecia O Rivera; Yunxin Ouyang; Regina Whitaker; Rebecca A Gibson; Christopher D Kontos; Andrew Berchuck; Rebecca A Previs; Xiling Shen
Journal:  Cell Rep       Date:  2022-06-28       Impact factor: 9.995

Review 5.  The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy.

Authors:  Galaxia M Rodriguez; Kristianne J C Galpin; Curtis W McCloskey; Barbara C Vanderhyden
Journal:  Cancers (Basel)       Date:  2018-07-24       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.